A Single Arm, Multicenter, Phase II Trial of RAD001 [everolimus] as Monotherapy in the Palliative Treatment of Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma After Failure of Platinum-Based Chemotherapy.

A Single Arm, Multicenter, Phase II Trial of RAD001 [everolimus] as Monotherapy in the Palliative Treatment of Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma After Failure of Platinum-Based Chemotherapy.